VVValentina Valentinovna Vtorushina

Valentina Valentinovna Vtorushina

*This is an algorithmically generated author record based on publicly available information.

Valentina Valentinovna Vtorushina has a total of 146 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Immune aging from the position of gynecological endocrinology: Starting point

    by Marina V. Averyanova, Polina A. Vishnyakova, Victoria V. Kiseleva, Valentiva V. Vtorushina, Lyubov V. Krechetova, Andrey V. Elchaninov, Timur Kh. Fatkhudinov, Svetlana V. Yureneva

    BACKGROUND: Postmenopause is accompanied by several body changes, including those in the immune system. Studying the molecular pathways linking the decrease in the level of sex steroids in the postmenopausal period with immune aging is important to completely understand the pathophysiology of immune aging, which will allow for accurate identification of potential therapy targets for autoimmune, oncological, cardiovascular diseases and prevention of infectious diseases in women during the postmenopausal period. AIM: To compare cellular immunity and cytokine profile parameters in women during perimenopause and early postmenopause. MATERIALS AND METHODS: The single-center, cross-sectional study included 50 women aged 45–59 years of reproductive stage, perimenopause, and early postmenopause. The main subpopulations of blood cells, namely, cytotoxic T lymphocytes (CD3+CD8+), T helper cells (CD3+CD4+), NK cells (CD56+CD16+), B lymphocytes (CD3–CD19+HLA–DR+), and classical (CD14++CD16–), nonclassical (CD14–CD16++), and intermediate (CD14+CD16++) monocytes and proinflammatory (CD86, CD80, CD40, and CX3CR1) and anti-inflammatory (CD163, CD206) markers on isolated monocyte populations were analyzed using flow cytometry (FACSCalibur; Becton Dickinson, USA). To detect blood plasma cytokines, a multiplex analysis method was used (Bio-Plex Human Cytokine Screening Panel; Bio-Rad Laboratories, USA). RESULTS: In women, reproductive aging during the transition stage of reproductive aging from perimenopause to postmenopause is accompanied by increased monocyte-associated inflammatory reaction and humoral response, which is expressed in the redistribution of the monocyte population toward nonclassical monocytes (p=0.034) and increased level of B lymphocytes by 1.8 times (p=0.023) and significantly (p=0.022) increases levels of MCP-1, a marker associated with inflammation. CONCLUSION: Immune system aging in both sexes is a natural process of ontogenesis, and in women, it correlates with the entry into the postmenopausal period. Hormonal background changes with the shutdown of ovarian function are naturally reflected in the composition of immune cells in the blood and the cytokine composition of its plasma.


  • Open Access

    Effect of Menopausal Hormone Therapy on Cellular Immunity Parameters and Cytokine Profile

    by Marina Averyanova, Svetlana Yureneva, Viktoriia Kiseleva, Oksana Yakushevskaya, Marina Iskusnykh, Anna Pavlova, Andrey Elchaninov, Timur Fatkhudinov, Natalia Mikhanoshina, Tatiana Ivanets, et al.

    Background: A woman’s entry into the menopause period is associated with a number of changes in the body, including those related to the immune system. Immune aging is a consequence of age-related changes in the function of immune cells and the composition of their subpopulations. Menopausal hormone therapy (MHT) is thought to partially neutralize the negative effects of aging on the immune system. Objective: We aimed to evaluate the effect of oral and transdermal MHT on cellular immunity parameters and cytokine profile in menopausal women. Methods: Fifty peri- and early postmenopausal women were included. Immune parameters were assessed by flow cytometry and multiplex analysis. Results: We showed that different routes of MHT administration led to significant changes in monocyte phenotype and a decrease in monocyte chemoattractant protein-1 (MCP-1) level in menopausal patients. In addition, oral MHT resulted in a significant increase in NK and B cells. A significant increase in the number of T-helper cells was observed with transdermal MHT. In addition, oral MHT resulted in a significant decrease in IL-1β level. Conclusions: We have demonstrated for the first time that oral therapy, in contrast to transdermal therapy, has a more pronounced effect on specific immune subpopulations of blood cells in menopausal women. This effect is likely to be responsible for its anti-aging properties in the context of immune aging as well as its protective effects in infectious diseases. Perhaps testing blood immune parameters or assessing immune status before prescribing MHT could become a routine step in clinical practice before choosing a patient management strategy.


  • Open Access

    Altered Monocyte and Lymphocyte Phenotypes Associated with Pathogenesis and Clinical Efficacy of Progestogen Therapy for Peritoneal Endometriosis in Adolescents

    by Elena P. Khashchenko, Lyubov V. Krechetova, Polina A. Vishnyakova, Timur Kh. Fatkhudinov, Eugeniya V. Inviyaeva, Valentina V. Vtorushina, Elena A. Gantsova, Viktoriia V. Kiseleva, Anastasiya S. Poltavets, Andrey V. Elchaninov, et al.

    Background: Immunological imbalances characteristic of endometriosis may develop as early as the primary manifestations of the disease in adolescence. Objective: To evaluate subpopulation dynamics of monocytes and lymphocytes in peripheral blood and peritoneal fluid of adolescents with peritoneal endometriosis at diagnosis and after 1-year progestogen therapy. Methods: This study included 70 girls, 13–17 years old, diagnosed laparoscopically with peritoneal endometriosis (n = 50, main group) or paramesonephric cysts (n = 20, comparison group). Phenotypes of monocytes and lymphocytes of the blood and macrophages of the peritoneal fluid were analyzed by flow cytometry at diagnosis and during progestogen therapy. Results: Differential blood counts of CD16+ (p < 0.001) and CD86+ (p = 0.017) monocytes were identified as independent risk factors for peritoneal endometriosis in adolescents. During the treatment, cytotoxic lymphocytes CD56dimCD16bright (p = 0.049) and CD206+ monocytes (p < 0.001) significantly increased while CD163+ monocytes decreased in number (p = 0.017). The CD56dimCD16bright blood counts before (p < 0.001) and during progestogen therapy (p = 0.006), as well as CD206+ blood counts during the treatment (p = 0.038), were associated with the efficacy of pain relief after 1-year progestogen therapy. Conclusions: Adolescents with peritoneal endometriosis have altered counts of pro- and anti-inflammatory monocytes and lymphocytes both before and after 1-year progestogen therapy, correlating with treatment efficacy and justifying long-term hormonal therapy.


  • Clinical and immunological characteristics of women in labor with COVID-19 and their newborn babies

    by Inviyaeva E.V. Inviyaeva, Tysyachnyi O.V. Tysyachnyi, Kosolapova Yu.A. Kosolapova, Vtorushina V.V. Vtorushina V, Baev O.R. Baev, Zubkov V.V. Zubkov, Krechetova L.V. Krechetova

  • Open Access

    Fecal cytokine profile in preterm infants in the diagnosis of necrotizing enterocolitis: pilot study results

    by E. E. Kosterina, E. N. Balashova, A. M. Krasnyi, A. R. Kirtbaya, A. A. Rudakova, A. A. Sadekova, V. V. Vtorushina, L. V. Krechetova, O. V. Ionov

    In this study, we sought to determine fecal cytokine levels in very preterm newborns at the onset of non-specific clinical symptoms of necrotizing enterocolitis (NEC) and decreased gastrointestinal (GI) motility. The study was approved by the Ethics Committee and the Scientific Council of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after the Academician V. I. Kulakov of Ministry of Healthcare of the Russian Federation. Each patient’s parents gave their informed consent to their child’s participation in the study. The study was conducted at the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after the Academician V. I. Kulakov over the period from June 2020 to December 2022. Fecal samples from preterm neonates with gestational age ≤ 32 weeks treated at the A.G. Antonov ICU were collected daily over their first 14 days of life. Samples from 46 newborns were selected for analysis: fecal samples collected on the day of an enteral feeding intolerance episode and fecal samples from controls who had not developed non-specific clinical symptoms of NEC or decreased GI motility, collected on the day when enteral intake reached 100 ml/kg/day. Based on the results of NEC and decreased GI motility diagnosis, stool samples were retrospectively divided into 3 groups: an NEC group (n = 8), a decreased GI motility group (n = 14) and a control group (n = 24). In the fecal samples of the very preterm newborns with NEC stage ≥ II, there was a significant increase in IL-6, IL-8, IL-10, TNF-a levels at the onset of initial symptoms of the disease. At the same time, the cytokine profile of the feces of the decreased GI motility patients did not differ significantly from the control group in any of the parameters. In cases of NEC, high IL-6, IL-8, IL-10 and TNF-a levels were detected in the patients’ stool at the onset of enteral feeding intolerance, suggesting that the method under investigation (aimed at determining the pro- and anti-inflammatory profile of fecal cytokines) may be a promising new tool for differentiating NEC from decreased GI motility in very preterm newborns.


  • Open Access

    The Effect of COVID-19 Severity, Associated Serum Autoantibodies and Time Interval after the Disease on the Outcomes of Fresh Oocyte ART Cycles in Non-Vaccinated Patients

    by Nataliya V. Dolgushina, Irina V. Menzhinskaya, Daria M. Ermakova, Natalia A. Frankevich, Valentina V. Vtorushina, Gennady T. Sukhikh

    It is assumed that SARS-CoV-2- and COVID-19-associated autoimmune processes may affect the outcomes of assisted reproductive technology (ART) cycles. This observational prospective study included 240 infertile patients: 105 patients had no history of COVID-19 (group 1) and 135 patients had experienced COVID-19 (group 2) in a mild (n = 85) or moderate (n = 50) form less than 12 months prior to oocyte retrieval. Using ELISAs, the profiles of their serum autoantibodies were determined, including antiphospholipid antibodies and antibodies to nuclear and thyroid antigens. The parameters of oogenesis and embryogenesis, as well as the pregnancy and childbirth rates, did not differ between groups 1 and 2, and also between the subgroups with different severities of COVID-19. However, when oocyte retrieval was performed less than 180 days after COVID-19, a higher proportion of poor-quality blastocysts was obtained (p = 0.006). A high risk of early miscarriage was found in the patients with moderate COVID-19. In group 2, IgG antibodies to annexin V, phosphatidylethanolamine (PE), and TSHr were detected more often than in group 1 (p = 0.035; p = 0.028; and p = 0.033, respectively), and a weak inverse correlation was revealed between anti-PE IgG and the number of oocytes and zygotes obtained. The results of the study suggest a possible adverse effect of COVID-19 and its associated autoantibodies on the outcomes of fresh oocyte ART cycles and early pregnancy, which depends on the severity of COVID-19 and the time interval after the disease.


  • Excess adipose tissue and chronic subclinical inflammation in patients with polycystic ovary syndrome

    by Kirillova E.D. Kirillova, Vtorushina V.V. Vtorushina, Krechetova L.V. Krechetova, Ivanets T.YU. Ivanets, Chernukha G.E. Chernukha


  • Cell subpopulation composition and cytokine content in peripheral blood before spontaneous and induced labor

    by Tysyachnyi O.V. Tysyachnyi, Inviyaeva E.V. Inviyaeva, Vtorushina V.V. Vtorushina, Krechetova L.V. Krechetova L, Baev O.R. Baev


  • The role of vascular and angiogenic factors in the development of selective fetal growth restriction in monochorionic multiple pregnancy

    by Gladkova K.A. Gladkova, Sakalo V.A. Sakalo, Vtorushina V.V. Vtorushina, Piskulina A.A. Piskulina, Frolova E.R. Frolova, Kostyukov K.V. Kostyukov, Khodzhaeva Z.S. Khodzhaeva


  • Open Access

    T-Cell Immunity in COVID-19-Recovered Individuals and Individuals Vaccinated with the Combined Vector Vaccine Gam-COVID-Vac

    by Sergey Petrovich Krechetov, Valentina Valentinovna Vtorushina, Evgenia Vladimirovna Inviyaeva, Elena Aleksandrovna Gorodnova, Svetlana Vladimirovna Kolesnik, Dmitry Anatolievich Kudlay, Pavel Igorevich Borovikov, Liubov Valentinovna Krechetova, Nataliya Vitalievna Dolgushina, Gennady Tikhonovich Sukhikh

    The COVID-19 pandemic has required extensive research on the new coronavirus SARS-CoV-2 and the creation of new highly effective vaccines. The presence of T-cells in the body that respond to virus antigens suggests adequate antiviral immunity. We investigated T-cell immunity in individuals who recovered from mild and moderate COVID-19 and in individuals vaccinated with the Gam-COVID-Vac combined vector vaccine. The ELISPOT method was used to determine the number of T-cells responding with IFN-γ synthesis to stimulation by peptides containing epitopes of the S-protein or N-, M-, ORF3, and ORF7 proteins, using peripheral blood mononuclear cells (PBMCs). At the same time, the multiplex method was used to determine the accumulation of IFN-γ and other cytokines in the culture medium. According to the data obtained, the proportion of positive conclusions about the T-cell immune response to SARS-CoV-2 antigens in control, recovered, and vaccinated individuals was 12%, 70%, and 52%, respectively. At the same time, more than half of the vaccinated individuals with a T-cell response were sensitized to the antigens of N-, M-, ORF3, and ORF7 proteins not produced by Gam-COVID-Vac, indicating a high likelihood of asymptomatic SARS-CoV-2 infection. Increased IFN-γ release by single sensitized T-cells in response to specific stimulation in recovered and vaccinated individuals did not result in the accumulation of this and other cytokines in the culture medium. These findings suggest a balance between cytokine production and utilization by immunocompetent cells as a prerequisite for providing a controlled cytokine signal and avoiding a “cytokine storm”.